Breaking

Anthropic Fights Trump Administration Over AI Model Export Controls Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz Election Conspiracy Theorist Wins Nevada GOP Secretary of State Primary Isar Aerospace Faces New Delays in Spectrum Rocket Test Flights Former Louisville Officer Charged with Manslaughter in Fatal Shooting Google CEO Sundar Pichai Faces Student Protest at Stanford Commencement Former ICE Acting Director Todd Lyons Hired by Defense Contractor Georgia GOP Primary Runoff Exposes Party Divisions Recall Issued for Alfredo Sauce Due to Potential Salmonella Contamination UN Security Council Urges Taliban to Reverse Women's Crackdown, Combat Militants Anthropic Fights Trump Administration Over AI Model Export Controls Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz Election Conspiracy Theorist Wins Nevada GOP Secretary of State Primary Isar Aerospace Faces New Delays in Spectrum Rocket Test Flights Former Louisville Officer Charged with Manslaughter in Fatal Shooting Google CEO Sundar Pichai Faces Student Protest at Stanford Commencement Former ICE Acting Director Todd Lyons Hired by Defense Contractor Georgia GOP Primary Runoff Exposes Party Divisions Recall Issued for Alfredo Sauce Due to Potential Salmonella Contamination UN Security Council Urges Taliban to Reverse Women's Crackdown, Combat Militants

early diagnosis

Steady1 stories1 sourcesLast updated: 6/3/2026

Related Topicscancer diagnosis biotechnology exosomes blood test multi-cancer screening precision medicine patent academic journal

Latest Stories

Bio firm Exopia develops blood-based multi-cancer early diagnosis tech with Japanese team

6/3/2026AI summary

Bio firm Exopia develops blood-based multi-cancer early diagnosis tech with Japanese team

Bio firm Exopia and a Japanese research team have developed a blood-based technology to simultaneously screen for five major cancers, including pancreatic, lung, breast, liver, and colon cancer, with an accuracy of about 94%.